Cargando…
Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration
Axonal degeneration is a key initiating event in many neurological diseases. Focal lesions to axons result in a rapid disintegration of the perilesional axon by acute axonal degeneration (AAD) within several hours. However, the underlying molecular mechanisms of AAD are only incompletely understood....
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109185/ https://www.ncbi.nlm.nih.gov/pubmed/27845394 http://dx.doi.org/10.1038/srep37050 |
_version_ | 1782467487024021504 |
---|---|
author | Zhang, Jian-Nan Michel, Uwe Lenz, Christof Friedel, Caroline C. Köster, Sarah d’Hedouville, Zara Tönges, Lars Urlaub, Henning Bähr, Mathias Lingor, Paul Koch, Jan C. |
author_facet | Zhang, Jian-Nan Michel, Uwe Lenz, Christof Friedel, Caroline C. Köster, Sarah d’Hedouville, Zara Tönges, Lars Urlaub, Henning Bähr, Mathias Lingor, Paul Koch, Jan C. |
author_sort | Zhang, Jian-Nan |
collection | PubMed |
description | Axonal degeneration is a key initiating event in many neurological diseases. Focal lesions to axons result in a rapid disintegration of the perilesional axon by acute axonal degeneration (AAD) within several hours. However, the underlying molecular mechanisms of AAD are only incompletely understood. Here, we studied AAD in vivo through live-imaging of the rat optic nerve and in vitro in primary rat cortical neurons in microfluidic chambers. We found that calpain is activated early during AAD of the optic nerve and that calpain inhibition completely inhibits axonal fragmentation on the proximal side of the crush while it attenuates AAD on the distal side. A screening of calpain targets revealed that collapsin response mediator protein-2 (CRMP2) is a main downstream target of calpain activation in AAD. CRMP2-overexpression delayed bulb formation and rescued impairment of axonal mitochondrial transport after axotomy in vitro. In vivo, CRMP2-overexpression effectively protected the proximal axon from fragmentation within 6 hours after crush. Finally, a proteomic analysis of the optic nerve was performed at 6 hours after crush, which identified further proteins regulated during AAD, including several interactors of CRMP2. These findings reveal CRMP2 as an important mediator of AAD and define it as a putative therapeutic target. |
format | Online Article Text |
id | pubmed-5109185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51091852016-11-25 Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration Zhang, Jian-Nan Michel, Uwe Lenz, Christof Friedel, Caroline C. Köster, Sarah d’Hedouville, Zara Tönges, Lars Urlaub, Henning Bähr, Mathias Lingor, Paul Koch, Jan C. Sci Rep Article Axonal degeneration is a key initiating event in many neurological diseases. Focal lesions to axons result in a rapid disintegration of the perilesional axon by acute axonal degeneration (AAD) within several hours. However, the underlying molecular mechanisms of AAD are only incompletely understood. Here, we studied AAD in vivo through live-imaging of the rat optic nerve and in vitro in primary rat cortical neurons in microfluidic chambers. We found that calpain is activated early during AAD of the optic nerve and that calpain inhibition completely inhibits axonal fragmentation on the proximal side of the crush while it attenuates AAD on the distal side. A screening of calpain targets revealed that collapsin response mediator protein-2 (CRMP2) is a main downstream target of calpain activation in AAD. CRMP2-overexpression delayed bulb formation and rescued impairment of axonal mitochondrial transport after axotomy in vitro. In vivo, CRMP2-overexpression effectively protected the proximal axon from fragmentation within 6 hours after crush. Finally, a proteomic analysis of the optic nerve was performed at 6 hours after crush, which identified further proteins regulated during AAD, including several interactors of CRMP2. These findings reveal CRMP2 as an important mediator of AAD and define it as a putative therapeutic target. Nature Publishing Group 2016-11-15 /pmc/articles/PMC5109185/ /pubmed/27845394 http://dx.doi.org/10.1038/srep37050 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Zhang, Jian-Nan Michel, Uwe Lenz, Christof Friedel, Caroline C. Köster, Sarah d’Hedouville, Zara Tönges, Lars Urlaub, Henning Bähr, Mathias Lingor, Paul Koch, Jan C. Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration |
title | Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration |
title_full | Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration |
title_fullStr | Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration |
title_full_unstemmed | Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration |
title_short | Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration |
title_sort | calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109185/ https://www.ncbi.nlm.nih.gov/pubmed/27845394 http://dx.doi.org/10.1038/srep37050 |
work_keys_str_mv | AT zhangjiannan calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration AT micheluwe calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration AT lenzchristof calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration AT friedelcarolinec calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration AT kostersarah calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration AT dhedouvillezara calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration AT tongeslars calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration AT urlaubhenning calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration AT bahrmathias calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration AT lingorpaul calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration AT kochjanc calpainmediatedcleavageofcollapsinresponsemediatorprotein2drivesacuteaxonaldegeneration |